Ohta S, Mizuno M, Takaoka T, Yoshida J
Department of Neurosurgery, Nagoya University School of Medicine, Japan.
J Neurooncol. 1997 Oct;35(1):7-11. doi: 10.1023/a:1005843600950.
We investigated the susceptibility of five human glioma cell lines to anti-Fas antibody. All human glioma cells tested constitutively expressed Fas antigen on their surfaces and the level of the expression varied slightly in each cell line. The cells had a low susceptibility to anti-Fas antibody-mediated apoptosis. There were four moderately resistant cell lines (U251-SP, U251-MG, SK-MG-1, T98) and one highly resistant cell line (U251 nu/nu). For this study we prepared liposomes containing anti-Fas antibody and studied the augmentation of the antibody-mediated apoptosis. The liposomes induced apoptosis significantly more often than did anti-Fas antibody alone. These results indicate that anti-Fas antibody-mediated apoptosis does not require a critical level of cell surface expression of Fas antigen but rather depends on the intensity of Fas signal transduction.
我们研究了五种人类胶质瘤细胞系对抗 Fas 抗体的敏感性。所有检测的人类胶质瘤细胞在其表面均组成性表达 Fas 抗原,且每种细胞系中该抗原的表达水平略有差异。这些细胞对抗 Fas 抗体介导的凋亡敏感性较低。有四个中度耐药细胞系(U251-SP、U251-MG、SK-MG-1、T98)和一个高度耐药细胞系(U251 nu/nu)。在本研究中,我们制备了含有抗 Fas 抗体的脂质体,并研究了抗体介导凋亡的增强情况。脂质体诱导凋亡的频率明显高于单独使用抗 Fas 抗体。这些结果表明,抗 Fas 抗体介导的凋亡并不需要 Fas 抗原在细胞表面表达达到临界水平,而是取决于 Fas 信号转导的强度。